Back to results
US 5,610,054 AGranted
Enzymatic RNA molecule targeted against Hepatitis C virus
AssigneeRibozyme Pharmaceuticals, Inc.
InventorKenneth G. Draper
Life of this patent
Estimating the term…
Abstract
An enzymatic RNA molecule which specifically cleaves RNA of a hepatitis C virus.
Claims16
An enzymatic RNA molecule which is active to specifically cleave RNA of hepatitis C virus (HCV).
Dependencies are inferred from the claim text.